Targeting the membrane-anchored serine protease testisin with a novel engineered anthrax toxin prodrug to kill tumor cells and reduce tumor burden-Reference-Cited by-同舟云学术

Targeting the membrane-anchored serine protease testisin with a novel engineered anthrax toxin prodrug to kill tumor cells and reduce tumor burden

Published:2015-09-15 Issue:32 Volume:6 Page:33534-33553
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Martin Erik W.¹,Buzza Marguerite S.¹,Driesbaugh Kathryn H.¹,Liu Shihui²,Fortenberry Yolanda M.³,Leppla Stephen H.²,Antalis Toni M.¹

Affiliation:

1. Center for Vascular and Inflammatory Diseases and the Department of Physiology, University of Maryland School of Medicine, Baltimore, MD 21201, USA

2. National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA

3. Division of Pediatric Hematology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extracellular: Plasma Membrane Proteases – Serine Proteases;Encyclopedia of Cell Biology;2023

2. Selective targeting of metastatic ovarian cancer using an engineered anthrax prodrug activated by membrane-anchored serine proteases;Proceedings of the National Academy of Sciences;2022-07-08

3. Imaging of anthrax intoxication in mice reveals shared and individual functions of surface receptors CMG-2 and TEM-8 in cellular toxin entry;Journal of Biological Chemistry;2022-01

4. Direct imaging of anthrax intoxication in animals reveals shared and individual functions of CMG-2 and TEM-8 in cellular toxin entry;2021-01-22

5. Unifying heterogeneous expression data to predict targets for CAR-T cell therapy;OncoImmunology;2021-01-01